Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
guido.antonelli@uniroma1.it
Guido Antonelli
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA MOLECOLARE
E-mail:
guido.antonelli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity
MICROORGANISMS
2023
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients
MICROORGANISMS
2023
Anti-N SARS-CoV-2 assays for evaluation of natural viral infection
JOURNAL OF IMMUNOLOGICAL METHODS
2023
Pfizer-BioNtech COVID-19 vaccine in gynecologic oncology patients: a prospective cohort study
VACCINES
2022
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study
MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL
2022
Safety of multiple vaccinations and durability of vaccine‐induced antibodies in an Italian military cohort 5 years after immunization
BIOMEDICINES
2022
HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis
VACCINES
2022
Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19
MICROORGANISMS
2022
Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
2022
Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity
EUROPEAN JOURNAL OF IMMUNOLOGY
2022
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020
SCIENTIFIC REPORTS
2022
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature
NEW MICROBIOLOGICA
2022
An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and blaNDM: evaluation of the global dissemination of these resistance determinants
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
2022
Serological Response and Relationship with Gender-Sensitive Variables among Healthcare Workers after SARS-CoV-2 Vaccination
JOURNAL OF PERSONALIZED MEDICINE
2022
Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω
FRONTIERS IN IMMUNOLOGY
2022
Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients
CELLS
2022
High prevalence of Merkel cell polyomavirus is associated with dysregulation in transcript levels of TLR9 and type I IFNs in a large cohort of CF patients from the Italian (Lazio) reference center for cystic fibrosis
MICROBIAL PATHOGENESIS
2022
The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults
CYTOKINE
2022
Common microbial genital infections and their impact on the innate immune response to HPV in cervical cells
PATHOGENS
2022
Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study
FRONTIERS IN IMMUNOLOGY
2022
1
2
3
4
5
6
7
8
seguente ›
ultima »
Progetti di Ricerca
COVID-19: Approaches for antiviral drug development
Bacterial/viral interactions in infection and immunity: application of the flow cytometry technology in different clinical settings
Ex vivo study on Type I and III interferon response and virus¿bacteria interactions in fibrosis cystic patients: a new approach to try to develop alternative therapeutic strategy
Gruppi di ricerca - Responsabile
Laboratorio di Virologia
Laboratori di ricerca
LABORATORIO DI VIROLOGIA
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma